Authors:
RIPOLL L
MAZOYER E
BAUDIN B
LACAM S
VARSAT B
DROUET LO
Citation: L. Ripoll et al., CAN HIGH PLASMA CERULOPLASMIN LEVELS CAUSE ACQUIRED ACTIVATED PROTEIN-C RESISTANCE, Thrombosis and haemostasis, 79(2), 1998, pp. 449-450
Authors:
RIPOLL L
KEREVEUR A
MAZOYER E
KUBIS N
WOIMANT F
DROUET LO
Citation: L. Ripoll et al., PIA PLATELET GPIIBIIIA POLYMORPHISM IS ASSOCIATED WITH INCREASED PLATELET-AGGREGATION AND RISK OF ISCHEMIC STROKE IN THE YOUNG, Circulation, 98(17), 1998, pp. 2409-2409
Authors:
DROUET L
MAZOYER E
SOLLIER CBD
HAINAUD P
RIPOLL L
Citation: L. Drouet et al., PARTICIPATION OF THROMBOTIC AND HEMOSTATIC MECHANISMS IN THE INITIAL-STAGES OF ATHEROSCLEROSIS, Archives des maladies du coeur et des vaisseaux, 91, 1998, pp. 41-51
Citation: L. Ripoll et al., DIFFERENT CONTRIBUTION OF FACTOR-V LEIDEN-ASSOCIATED HYPERCOAGULABILITY TO ISCHEMIC CEREBROVASCULAR-DISEASE IN THE ELDERLY, Blood coagulation & fibrinolysis, 8(4), 1997, pp. 253-254
Authors:
BENTOLILA S
RIPOLL L
DROUET L
CRASSARD I
TOURNIERLASSERVE E
PIETTE JC
Citation: S. Bentolila et al., LACK OF ASSOCIATION BETWEEN THROMBOSIS IN PRIMACY ANTIPHOSPHOLIPID SYNDROME AND THE RECENTLY DESCRIBED THROMBOPHILIC 3'-UNTRANSLATED PROTHOMBIN GENE POLYMORPHISM, Thrombosis and haemostasis, 78(5), 1997, pp. 1415-1415
Citation: L. Ripoll et al., MULTIPLEX PCR-MEDIATED SITE-DIRECTED MUTAGENESIS FOR ONE-STEP DETERMINATION OF FACTOR-V-LEIDEN AND G20210A TRANSITION OF THE PROTHROMBIN GENE, Thrombosis and haemostasis, 78(2), 1997, pp. 960-961
Authors:
BENTOLILA S
RIPOLL L
DROUET L
MAZOYER E
WOIMANT F
Citation: S. Bentolila et al., THROMBOPHILIA DUE TO 20210-G-]A PROTHROMBIN POLYMORPHISM AND CEREBRAL-ISCHEMIA IN THE YOUNG, Stroke, 28(9), 1997, pp. 1846-1847
Authors:
BENTOLILA S
RIPOLL L
DROUET L
CRASSARD I
TOURNIERLASSERVE E
PIETTE JC
Citation: S. Bentolila et al., COMMON PROTHROMBOTIC GENETIC-FACTORS ARE ADDITIONAL RISKS FOR THROMBOSIS IN MEN WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME (PAPS), Arthritis and rheumatism, 40(9), 1997, pp. 1608-1608
Citation: L. Ripoll et al., INTERACTION OF MACROLIDES WITH ALPHA-DORNASE DURING DNA HYDROLYSIS, Journal of antimicrobial chemotherapy, 37(5), 1996, pp. 987-991
Citation: E. Mazoyer et al., ATHERO-THROMBOTIC RISK AND COAGULATION-FA CTORS IN WOMEN, Archives des maladies du coeur et des vaisseaux, 89, 1996, pp. 17-24
Authors:
LAPLANCHE JL
BEAUDRY P
RIPOLL L
LAUNAY JM
Citation: Jl. Laplanche et al., PRION PROTEIN - STRUCTURE, FUNCTIONS AND HUMAN SPONGIFORM ENCEPHALOPATHIES-ASSOCIATED POLYMORPHISMS, Pathologie et biologie, 43(2), 1995, pp. 104-113
Authors:
DROUET L
MAZOYER E
RIPOLL L
DOSQUET C
TOBELEM G
Citation: L. Drouet et al., FIBRINOGEN PHENOTYPE (PLASMA-LEVEL AND ACTIVITY) AND GENOTYPE IN ATHEROTHROMBOTIC PATIENTS EVOLUTION AFTER TICLOPIDINE TREATMENT, Thrombosis and haemostasis, 73(6), 1995, pp. 1379-1379
Citation: Mr. Boisseau et al., DOES TICLOPIDINE TREATMENT LOWER PLASMA-FIBRINOGEN - A REVIEW OF THE LITERATURE, Clinical hemorheology, 14(2), 1994, pp. 171-180
Authors:
RIPOLL L
LAPLANCHE JL
SALZMANN M
JOUVET A
PLANQUES B
DUSSAUCY M
CHATELAIN J
BEAUDRY P
LAUNAY JM
Citation: L. Ripoll et al., A NEW POINT MUTATION IN THE PRION PROTEIN GENE AT CODON 210 IN CREUTZFELDT-JAKOB-DISEASE, Neurology, 43(10), 1993, pp. 1934-1938